Literature DB >> 5914349

Ocular toxic changes associated with chlorpromazine and thioridazine.

J R Siddall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5914349

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  7 in total

Review 1.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 2.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

3.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

4.  Pigmentary retinopathy associated with low-dose thioridazine treatment.

Authors:  R W Lam; R A Remick
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

Review 5.  Phenylketonuria does not cause cataracts.

Authors:  D B Pitt; J O'Day
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 6.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

7.  Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis.

Authors:  Pantaleo Fornaro; Giovanni Calabria; Guido Corallo; Giovanni B Picotti
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.